- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Recordati Pharmaceutical company
Total 512 results
-
LG Life SciencesMochida Pharmaceutical Company, Ltd.UnknownArthritis, RheumatoidJapan, Korea, Republic of
-
Medical University of SilesiaPolpharma Pharmaceutical CompanyTerminatedFirst Time Dual Chamber Pacemaker ImplantationPoland
-
LG Life SciencesMochida Pharmaceutical Company, Ltd.CompletedArthritis, RheumatoidJapan, Korea, Republic of
-
Seoul National University HospitalCW pharmaceutical companyUnknownCardiac AmyloidosisKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedSeoul National UniversityCompletedAdvanced Solid TumorKorea, Republic of
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingPrimary Hyperoxaluria Type 3 | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1 | Primary HyperoxaluriaUnited States, Canada, Lebanon, Turkey, United Kingdom, Germany, Italy, Japan, Poland, Spain, United Arab Emirates
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyActive, not recruitingPrimary Hyperoxaluria Type 3United States, Germany, United Kingdom, Canada, Poland
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyAvailablePrimary Hyperoxaluria Type 1 (PH1)
-
InfaCare Pharmaceuticals Corporation, a Mallinckrodt...CompletedHyperbilirubinemia, Neonatal | Jaundice, NeonatalUnited States
-
InfaCare Pharmaceuticals Corporation, a Mallinckrodt...Terminated
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingSolid Tumor, Adult | Refractory TumorUnited States
-
Suzhou Raymon Pharmaceuticals Company, Ltd.WuXi ClinicalActive, not recruiting
-
Vtesse, LLC, a Mallinckrodt Pharmaceuticals CompanyCompletedNiemann-Pick Disease, Type C1United States
-
InfaCare Pharmaceuticals Corporation, a Mallinckrodt...CompletedHyperbilirubinemia, Neonatal
-
InfaCare Pharmaceuticals Corporation, a Mallinckrodt...TerminatedHyperbilirubinemia, NeonatalUnited States, Spain, Poland, Ukraine
-
InfaCare Pharmaceuticals Corporation, a Mallinckrodt...No longer availableHyperbilirubinemia | Neonatal JaundiceUnited States
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingEnd Stage Renal Disease | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1Germany, Spain, United States, United Kingdom, Italy, United Arab Emirates, Lebanon, Morocco, France, Romania
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyActive, not recruitingAlpha 1-Antitrypsin DeficiencyUnited Kingdom, United States, Ireland, Belgium, New Zealand, Spain, Netherlands, Portugal, Canada, Australia, France, Austria, Germany, Sweden
-
Vtesse, LLC, a Mallinckrodt Pharmaceuticals CompanyWithdrawnNiemann-Pick Disease, Type C
-
InfaCare Pharmaceuticals Corporation, a Mallinckrodt...Completed
-
InfaCare Pharmaceuticals Corporation, a Mallinckrodt...CompletedJaundice | Neonatal Hyperbilirubinemia
-
Stiefel, a GSK CompanyBasilea PharmaceuticaCompleted
-
Stiefel, a GSK CompanyBasilea PharmaceuticaCompletedPsoriasisFrance, Germany, United Kingdom, Netherlands
-
Tetraphase Pharmaceuticals, Inc.National Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Tetraphase Pharmaceuticals, Inc.National Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Tetraphase Pharmaceuticals, Inc.National Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Tetraphase Pharmaceuticals, Inc.National Institute of Allergy and Infectious Diseases (NIAID)Completed
-
University of New MexicoLa Jolla Pharmaceutical CompanyRecruitingSeptic Shock | Vasodilatory ShockUnited States
-
Asan Medical CenterChong Kun Dang Pharmaceutical CompanyRecruitingTricuspid Regurgitation | Right Ventricular DilatationKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedMerck Sharp & Dohme LLCCompletedGastric CancerKorea, Republic of
-
Mochida Pharmaceutical Company, Ltd.Fuji Yakuhin Co., Ltd.Completed
-
Konkuk University Medical CenterHanmi Pharmaceutical Company LimitedCompletedNon Small Cell Lung CancerKorea, Republic of
-
Korea University Guro HospitalHanmi Pharmaceutical Company LimitedCompletedHepatocellular CarcinomaKorea, Republic of
-
Tehran University of Medical SciencesRojanPharma Pharmaceutical CompanyCompletedHuman Immunodeficiency Virus | Hepatitis C Virus Infection, Response to Therapy ofIran, Islamic Republic of
-
Fuji Yakuhin Co., Ltd.Mochida Pharmaceutical Company, Ltd.Completed
-
Mochida Pharmaceutical Company, Ltd.Fuji Yakuhin Co., Ltd.CompletedHyperuricemia With or Without GoutJapan
-
Korea University Guro HospitalHanmi Pharmaceutical Company LimitedCompletedAtrial FibrillationKorea, Republic of
-
Kyungpook National University HospitalHanmi Pharmaceutical Company LimitedUnknownGlomerulonephritis, MembranousKorea, Republic of
-
Kingman Regional Medical CenterLa Jolla Pharmaceutical CompanyRecruitingSepsis | Systemic Inflammatory Response Syndrome | Shock | Septic ShockUnited States
-
Fuji Yakuhin Co., Ltd.Mochida Pharmaceutical Company, Ltd.CompletedHyperuricemia With or Without GoutJapan
-
Mochida Pharmaceutical Company, Ltd.Fuji Yakuhin Co., Ltd.CompletedHyperuricemia With or Without GoutJapan
-
Fuji Yakuhin Co., Ltd.Mochida Pharmaceutical Company, Ltd.Completed
-
Mochida Pharmaceutical Company, Ltd.Fuji Yakuhin Co., Ltd.Completed
-
Mutual Pharmaceutical Company, Inc.Cetero Research, San AntonioCompleted
-
POLYSAN Scientific & Technological Pharmaceutical...Atlant Clinical Ltd.CompletedMetabolic AcidosisRussian Federation
-
Mochida Pharmaceutical Company, Ltd.Fuji Yakuhin Co., Ltd.CompletedHepatic Insufficiency | HealthyJapan
-
Alexion Pharmaceuticals, Inc.Eidos Therapeutics, a BridgeBio companyActive, not recruitingSymptomatic Transthyretin Amyloid CardiomyopathyJapan